Chronic allograft nephropathy

被引:68
作者
Cornell, LD [1 ]
Colvin, RB [1 ]
机构
[1] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
关键词
calcineurin inhibitor toxicity; chronic allograft nephropathy; chronic rejection; kidney transplant;
D O I
10.1097/01.mnh.0000165888.83125.07
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review Chronic allograft nephropathy is the major cause of late renal allograft loss. This disease is heterogenous and the diagnosis is nonspecific, with both immune and nonimmune causes. Increasingly, we are able to recognise specific contributions to the disease. Recent findings Further understandings of chronic allograft nephropathy comes from a large study detailing the natural history of the disease, from protocol biopsies revealing subclinical cellular rejection, and from studies using C4d staining to distinguish antibody-mediated chronic rejection from nonspecific causes. Also made more clear are nonimmune mechanisms of chronic allograft nephropathy, such as the effect of decreased dosing of calcineurin inhibitors, and the concept of senescence as a mechanism of the disease. Summary Chronic allograft nephropathy is a heterogeneous disease with immune and nonimmune causes. Some features recognisable by histology and detected by other laboratory tests to help to categorize specific causes of the disease in particular cases. In addition, recent studies have contributed to our knowledge of the pathogenesis of the disease. In order to advance our understanding, we must be able to distinguish the various recognizable causes of chronic allograft dysfunction. Further research is warranted subset of the disease with indeterminate cause.
引用
收藏
页码:229 / 234
页数:6
相关论文
共 55 条
  • [1] Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy
    Artz, MA
    Hilbrands, LB
    Borm, G
    Assmann, KJM
    Wetzels, JFM
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (11) : 2852 - 2857
  • [2] BACH FH, 1991, TRANSPL P, V23, P205
  • [3] Diagnosis and treatment of antibody-mediated kidney allograft rejection
    Böhmig, G
    Regele, H
    [J]. TRANSPLANT INTERNATIONAL, 2003, 16 (11) : 773 - 787
  • [4] Increased expression of p16(INK4a) and p27(Kip1) cyclin-dependent kinase inhibitor genes in aging human kidney and chronic allograft nephropathy
    Chkhotua, AB
    Gabusi, E
    Altimari, A
    D'Errico, A
    Yakubovich, M
    Vienken, J
    Stefoni, S
    Chieco, P
    Yussim, A
    Grigioni, WF
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (06) : 1303 - 1313
  • [5] Collins AB, 1999, J AM SOC NEPHROL, V10, P2208
  • [6] COLVIN RB, 1998, HEPTINSTALLS PATHOLO
  • [7] CORNELL L, 2004, MODERN PATHOL, V17, pA285
  • [8] Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis
    Del Prete, D
    Gambaro, G
    Lupo, A
    Anglani, F
    Brezzi, B
    Magistroni, R
    Graziotto, R
    Furci, L
    Modena, F
    Bernich, P
    Albertazzi, A
    D'Angelo, A
    Maschio, G
    [J]. KIDNEY INTERNATIONAL, 2003, 64 (01) : 149 - 159
  • [9] DZAU VJ, 1988, CIRCULATION, V77, P11
  • [10] The role of replicative senescence in chronic allograft nephropathy
    Ferlicot, S
    Durrbach, A
    Bâ, N
    Desvaux, D
    Bedossa, P
    Paradis, V
    [J]. HUMAN PATHOLOGY, 2003, 34 (09) : 924 - 928